BGI Genomics Co's Total Assets for the quarter that ended in Mar. 2024 was ¥13,457 Mil.
Warning Sign:
If a company builds assets at 17.2% a year, faster than its revenue growth rate of 15.4% over the past 5 years, it means that the company may be getting less efficient.
During the past 12 months, BGI Genomics Co's average Total Assets Growth Rate was 10.60% per year.
During the past 3 years, the average Total Assets Growth Rate was 11.10% per year.
During the past 5 years, the average Total Assets Growth Rate was 17.20% per year.
During the past 10 years, the average Total Assets Growth Rate was 18.80% per year.
During the past 12 years, BGI Genomics Co's highest 3-Year average Total Assets Growth Rate was 73.40%. The lowest was 2.10%. And the median was 15.90%.
The historical data trend for BGI Genomics Co's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
BGI Genomics Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BGI Genomics Co (SZSE:300676) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Mar. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
BGI Genomics Co's Asset Turnover for the quarter that ended in Mar. 2024 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
BGI Genomics Co Total Assets Related Terms
Thank you for viewing the detailed overview of BGI Genomics Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
BGI Genomics Co (SZSE:300676) Business Description
BGI Genomics Co Ltd is a China-based company principally engaged in the provision of genomic class diagnosis and research services through the application of biotechnology. It offers its services in various research areas, such as agriculture and food science, cancer research, metagenomics, reproductive health, biomarker discovery, and drug discovery. The company mainly provides services for domestic and overseas academic institutions hospitals, medical institutions and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:300676 has been successfully added to your 